133 related articles for article (PubMed ID: 19199331)
21. Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.
Suster D; Michal M; Huang H; Ronen S; Springborn S; Debiec-Rychter M; Billings SD; Goldblum JR; Rubin BP; Michal M; Suster S; Mackinnon AC
Mod Pathol; 2020 Dec; 33(12):2520-2533. PubMed ID: 32514165
[TBL] [Abstract][Full Text] [Related]
22. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
[TBL] [Abstract][Full Text] [Related]
23. Epithelioid Cutaneous Mesenchymal Neoplasms: A Practical Diagnostic Approach.
Choi JH; Ro JY
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32316685
[TBL] [Abstract][Full Text] [Related]
24. Primary hemosiderotic fibrolipomatous tumor in bone: a case report and review of the literature.
Hou W; Li C; Guo C; Zhang L; Meng X; Liu Q; Wang J
Int J Clin Exp Pathol; 2018; 11(5):2497-2505. PubMed ID: 31938362
[No Abstract] [Full Text] [Related]
25. What's new in fibroblastic tumors?
Armstrong SM; Demicco EG
Virchows Arch; 2020 Jan; 476(1):41-55. PubMed ID: 31828431
[TBL] [Abstract][Full Text] [Related]
26. Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor.
Rougemont AL; Berczy M; Lin Marq N; McKee TA; Christinat Y
Virchows Arch; 2019 Aug; 475(2):251-254. PubMed ID: 30911815
[TBL] [Abstract][Full Text] [Related]
27. Evaluation and Immunolocalization of BMP4 and FGF8 in Odontogenic Cyst and Tumors.
Swarup N; Nayak MT; Chowdhary Z; Mehendiratta M; Khatana S; Choi SJ; Sagolsem C
Anal Cell Pathol (Amst); 2018; 2018():1204549. PubMed ID: 30079292
[TBL] [Abstract][Full Text] [Related]
28. Aggressive myxoinflammatory fibroblastic sarcoma with multiple site metastases.
Srivastava P; Husain N; Neyaz A; Gupta V
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30021730
[TBL] [Abstract][Full Text] [Related]
29. Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation.
Hallin M; Miki Y; Hayes AJ; Jones RL; Fisher C; Thway K
Rare Tumors; 2018; 10():2036361318782626. PubMed ID: 29977483
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas.
Agostini A; Brunetti M; Davidson B; Göran Tropé C; Heim S; Panagopoulos I; Micci F
Int J Cancer; 2018 Sep; 143(6):1379-1387. PubMed ID: 29633253
[TBL] [Abstract][Full Text] [Related]
31. Vestigial-like 3 is a novel Ets1 interacting partner and regulates trigeminal nerve formation and cranial neural crest migration.
Simon E; Thézé N; Fédou S; Thiébaud P; Faucheux C
Biol Open; 2017 Oct; 6(10):1528-1540. PubMed ID: 28870996
[No Abstract] [Full Text] [Related]
32. Sarcomatous transformation of a hemosiderotic fibrohistiocytic lipomatous tumor: a case report.
Etchebehere RM; Almeida ECS; Santos CDT; Micheletti AMR; Leitão AS
Rev Bras Ortop; 2017; 52(3):366-369. PubMed ID: 28702400
[TBL] [Abstract][Full Text] [Related]
33. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
34. From vestigial to vestigial-like: the Drosophila gene that has taken wing.
Simon E; Faucheux C; Zider A; Thézé N; Thiébaud P
Dev Genes Evol; 2016 Jul; 226(4):297-315. PubMed ID: 27116603
[TBL] [Abstract][Full Text] [Related]
35. An unusual karyotype in leiomyoma: Case report and literature review.
Chang L; Rao N; Bernthal N; Dry SM; James AW
J Orthop; 2015 Dec; 12(Suppl 2):S251-4. PubMed ID: 27047231
[TBL] [Abstract][Full Text] [Related]
36. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.
Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805820
[TBL] [Abstract][Full Text] [Related]
37. Myxoinflammatory fibroblastic sarcoma: spectrum of disease and imaging presentation.
Gaetke-Udager K; Yablon CM; Lucas DR; Morag Y
Skeletal Radiol; 2016 Mar; 45(3):347-56. PubMed ID: 26563559
[TBL] [Abstract][Full Text] [Related]
38. A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.
Deel MD; Li JJ; Crose LE; Linardic CM
Front Oncol; 2015; 5():190. PubMed ID: 26389076
[TBL] [Abstract][Full Text] [Related]
39. Myxoinflammatory Fibroblastic Sarcoma: A Radiographical, Pathological, and Immunohistochemical Report of Rare Malignancy.
Kato M; Tanaka T; Ohno T
Case Rep Orthop; 2015; 2015():620923. PubMed ID: 26090253
[TBL] [Abstract][Full Text] [Related]
40. Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center.
O'Driscoll D; Athanasian E; Hameed M; Hwang S
Skeletal Radiol; 2015 May; 44(5):641-8. PubMed ID: 25527465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
